This inventor holds 15 USPTO granted patents and 3 published patent applications, primarily in Genetic Mutation Detection. Top assignees: Kineta Two, LLC, Illumigen Biosciences, Inc., Ib Security Holders LLC. Active years: 2006-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
11 out of 11 
3 out of 4 
1 out of 1 Years Active: 2006-2015
Areas of Expertise:
Title: Innovator and Inventor Charles Lee Magness: Leading Advancements in Viral Resistance
Introduction: Charles Lee Magness, based in Seattle, WA, is a prominent inventor known for his groundbreaking work in genetics and virology. With a remarkable portfolio of 15 patents, he has established himself as a pioneer in understanding and combating viral infections.
Latest Patents: Among his recent contributions to the field are two notable patents that delve into the genetic mechanisms behind viral resistance. The first patent focuses on mutations in OAS1 genes, which include modified amino acid sequences of OAS1 proteins in non-human primates. This discovery is essential for understanding how certain genetic configurations can influence resistance to various viral infections. His second patent presents a method for detecting mutations in the OAS1 gene, which encodes for proteins associated with resistance against viral infections, including hepatitis C. This patent also offers insights into therapeutic agents consisting of proteins or polypeptides encoded by the mutated gene. Additionally, it discusses inhibitors of human OAS1, including antisense oligonucleotides and related methods, enhancing the potential for targeted antiviral therapies.
Career Highlights: Magness's career is marked by significant advancements in the biotech industry, particularly in the realm of infectious diseases. His work contributes valuable knowledge and potential therapeutic approaches for various viral infections, showcasing his innovative spirit and commitment to public health.
Collaborations: Throughout his career, Charles Lee Magness has collaborated with esteemed professionals in the field, including Shawn P. Iadonato and Christina A. Scherer. Their collective efforts have propelled advancements in genetic research and therapeutic development, strengthening the impact of their work on viral resistance.
Conclusion: Charles Lee Magness exemplifies the innovative spirit of modern inventors, leveraging his expertise to advance scientific understanding and therapeutic options in the fight against viral infections. With his impressive portfolio of patents and collaborations, he continues to pave the way for future research and advancements in genetics and virology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile